NCT03472924

The Effects of Kinesio Tape® on Arthrogenic Muscle Inhibition and Rate of Torque Development

Terminated NA Results posted Last updated 19 March 2024

What this trial tests

NA trial testing Kinesiotaping in Neural Inhibition in 6 participants. Terminated before completion.

Timeline

16 April 2018

Primary endpoint
15 June 2020

15 June 2020

Quick facts

Lead sponsor	Oregon State University
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	6
Start date	16 April 2018
Primary completion	15 June 2020
Estimated completion	15 June 2020
Sites	1 location across United States

Drugs / interventions tested

• Kinesiotaping

Conditions studied

• Neural Inhibition — all drugs for Neural Inhibition →
• Injuries, Ankle — all drugs for Injuries, Ankle →

Sponsor

Oregon State University

Who can join

Adults 18 to 35, any sex, with Neural Inhibition or Injuries, Ankle. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Change in Central Activation Ratio Primary · Change between baseline and 2 days post-intervention

Ratio between maximal voluntary evertor torque and torque produced following the application of an exogenous electrical stimulus

Group	Value	95% CI
Kinesio Tape	0.003	± 0.024
Control	0.015	± 0.035

Change in Rate of Torque Development Primary · Change between baseline and 2 days post-intervention

Measure of explosive strength determined by placing a line of best fit to a recorded torque-time curve from onset to 100ms after onset

Group	Value	95% CI
Kinesio Tape	-0.130	± 0.171
Control	-0.024	± 0.010

Change in Maximal Voluntary Isometric Contraction Secondary · Change between baseline and 2 days post-intervention

Measure of maximal voluntary isometric torque that participant can produce

Group	Value	95% CI
Kinesio Tape	0.001	± 0.037
Control	0.035	± 0.043

Adverse events — posted to ClinicalTrials.gov

Time frame: 3 days (Time of kinesotape application to post-testing session 3 days later). Reporting threshold: 5%. Adverse-event reports describe events observed during the trial — not all are caused by the drug.

Kinesio Tape

Serious: 0/4 (0%)

Deaths: 0/4

Control

Serious: 0/2 (0%)

Deaths: 0/2

Other adverse events (1 terms — click to expand)

Reaction	System	Kinesio Tape	Control
Skin irritation	Skin and subcutaneous tissue disorders	—	—

Data from ClinicalTrials.gov NCT03472924 adverse events section.

Sponsor's own description

This study evaluates whether the use of Kinesio Tape® in combination with a standard exercise program improves muscle function in individuals with chronic ankle instability. Twenty participants will receive Kinesio Tape® and perform an ankle exercise program, while twenty will perform the ankle exercise program without Kinesio Tape®.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.